Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation

Journal of the American College of Cardiology

Volumn 56, Issue 21, 2010, Pages 1712-1719

  Smith, J Gustav ^a,b   Newton Cheh, Christopher ^b,c   Almgren, Peter ^a   Struck, Joachim ^d   Morgenthaler, Nils G ^d   Bergmann, Andreas ^d   Platonov, Pyotr G ^a   Hedblad, Bo ^a   Engstrm, Gunnar ^a   Wang, Thomas J ^c   Melander, Olle ^a  

^a LUND UNIVERSITY   (Sweden)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

atrial fibrillation; epidemiology; heart failure; natriuretic peptides; prediction; risk factors

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; CYSTATIN C; MIDREGIONAL PROATRIAL NATRIURETIC PEPTIDE; PROADRENOMEDULLIN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SWEDEN; TIME FACTORS;

EID: 78349296417     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.05.049     Document Type: Article

References (38)

1. E. Braunwald Shattuck lecturecardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities N Engl J Med 337 1997 1360 1369
2. W.H. Maisel, and L.W. Stevenson Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy Am J Cardiol 91 Suppl 2003 2D 8D
3. V.L. Roger, S.A. Weston, and M.M. Redfield Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
4. S. Stewart, C.L. Hart, D.J. Hole, and J.J.V. McMurray A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 2002 359 364
5. D.M. Lloyd-Jones, M.G. Larson, and E.P. Leip Lifetime risk for developing congestive heart failure: the Framingham heart study Circulation 106 2002 3068 3072
6. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip Lifetime risk for development of atrial fibrillation: the Framingham heart study Circulation 110 2004 1042 1046
7. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 53 2009 e1 e90
8. E.J. Benjamin, P.S. Chen, and D.E. Bild Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop Circulation 119 2009 606 618
9. W.B. Kannel, and A.J. Belanger Epidemiology of heart failure Am Heart J 121 1991 951 957
10. J.S. Gottdiener, A.M. Arnold, and G.P. Aurigemma Predictors of congestive heart failure in the elderly: the Cardiovascular Health study J Am Coll Cardiol 35 2000 1628 1637
11. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort The Framingham Heart study JAMA 271 1994 840 844
12. B.M. Psaty, T.A. Manolio, and L.H. Kuller Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 1997 2455 2461
13. W.B. Kannel, R.B. D'Agostino, H. Silbershatz, A.J. Belanger, P.W. Wilson, and D. Levy Profile for estimating risk of heart failure Arch Intern Med 159 1999 1197 1204
14. R.B. Schnabel, L.M. Sullivan, and D. Levy Development of a risk score for atrial fibrillation (Framingham Heart study): a community-based cohort study Lancet 373 2009 739 745
15. J. Butler, A. Kalogeropoulos, and V. Georgiopoulou Incident heart failure prediction in the elderly The Health ABC Heart Failure Score Circ Heart Fail 1 2008 125 133
16. E. Braunwald Biomarkers in heart failure N Engl J Med 358 2008 2148 2159
17. T.J. Wang, M.G. Larson, and D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
18. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
19. N.R. Cook Use and misuse of the receiver operating characteristic curve in risk prediction Circulation 115 2007 928 935
20. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr, and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 20712
21. M.A. Hlatky, P. Greenland, and D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk A scientific statement from the American Heart Association Circulation 119 2009 2408 2416
22. O. Melander, C. Newton-Cheh, and P. Almgren Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 2009 49 57
23. E. Ingelsson, J. Arnlv, J. Sundstrm, and L. Lind The validity of a diagnosis of heart failure in a hospital discharge register Eur J Heart Fail 7 2005 787 791
24. N. Hammar, L. Alfredsson, M. Rosn, C.L. Spetz, T. Kahan, and A.S. Ysberg A national record linkage to study acute myocardial infarction incidence and case fatality in sweden Int J Epidemiol 30 Suppl 1 2001 S30 S34
25. J.G. Smith, P.G. Platonov, B. Hedblad, G. Engstrm, and O. Melander Atrial fibrillation in the Malm diet and cancer study: a study of occurrence, risk factors and diagnostic validity Eur J Epidemiol 25 2010 95 102
26. J.K. Grønnesby, and O. Borgan A method for checking regression models in survival analysis based on the risk score Lifetime Data Anal 2 1996 315 328
27. P.W.F. Wilson, S.C. Smith, R.S. Blumenthal, G.L. Burke, and N.D. Wong Task force #4how do we select patients for atherosclerosis imaging? 34th Bethesda conference: can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease J Am Coll Cardiol 41 2003 1898 1906
28. T.J. Wang, P. Gona, and M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
29. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
30. S. Yusuf, S. Hawken, and S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the Interheart study): case-control study Lancet 364 2004 937 952
31. A. Kalogeropoulos, V. Georgiopoulou, and S.B. Kritchevsky Epidemiology of incident heart failure in a contemporary elderly cohort: the Health, Aging, and Body Composition study Arch Intern Med 169 2009 708 715
32. L.C. Costello-Boerrigter, G. Boerrigter, and M.M. Redfield Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction J Am Coll Cardiol 47 2006 345 353
33. C. Tschpe, M. Kasner, D. Westermann, R. Gaub, W.C. Poller, and H. Schultheiss The role of Nt-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements Eur Heart J 26 2005 2277 2284
34. P. Jong, S. Yusuf, M.F. Rousseau, S.A. Ahn, and S.I. Bangdiwala Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study Lancet 361 2003 1843 1848
35. T.J. Wang, J.C. Evans, E.J. Benjamin, D. Levy, E.C. LeRoy, and R.S. Vasan Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
36. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
37. T.J. Wang, D. Levy, E.J. Benjamin, and R.S. Vasan The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening Ann Intern Med 138 2003 907 916
38. P.A. Heidenreich, M.A. Gubens, G.C. Fonarow, M.A. Konstam, L.W. Stevenson, and P.G. Shekelle Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019 1026